A limited number of studies assessed the physiological role of CD30/CD30 ligand interactions in control of infection and it has been shown that after Epstein-Barr (EBV) infection, large numbers of CD30+ cells are generated (Zhou et al., 2017). Here, TNFRSF8 is linked to infection.